ABOS
Acumen Pharmaceuticals Inc.
$1.28
+$0.02(+1.59%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$76.32M
Volume
203.98K
52W Range
$0.86 - $3.36
Target Price
$7.60
EPS Estimates Overview
| Current Quarter | $-0.63 | Next Quarter | $-0.63 |
| Current Year | $-2.24 | Next Year | $-1.58 |
| QoQ Growth | +0.0% | YoY Growth | +29.5% |
| 3Y EPS CAGR | +30.2% | Target Price | $7.60 |
| Consensus | Buy | Upside | +493.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABOS | $1.28 | +1.6% | 203.98K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Acumen Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW